1,599
Views
5
CrossRef citations to date
0
Altmetric
Research Article

RDM1 plays an oncogenic role in human ovarian carcinoma cells

, , , , , , & show all
Pages 885-892 | Received 11 Oct 2019, Accepted 06 Jan 2020, Published online: 05 Jun 2020

References

  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
  • Marcus CS, Maxwell GL, Darcy KM, et al. Current approaches and challenges in managing and monitoring treatment response in ovarian cancer. J Cancer. 2014;5(1):25–30.
  • Touboul C, Vidal F, Pasquier J, et al. Role of mesenchymal cells in thenatural history of ovarian cancer: a review. J Transl Med. 2014;12:271.
  • Anurag M, Punturi N, Hoog J, et al. Comprehensive profiling of DNA repair defects in breast cancer identifies a novel class of endocrine therapy resistance drivers. Clin Cancer Res. 2018;24(19):4887–4899.
  • van den Bosch M, Lohman PH, Pastink A. DNA double-strand break repair by homologous recombination. Biol. Chem. 2002;383(6):873–892.
  • West SC. Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol. 2003;4(6):435–445.
  • Messaoudi L, Yang Y-G, Kinomura A, et al. Subcellular distribution of human RDM1 protein isoforms and their nucleolar accumulation in response to heat shock and proteotoxic stress. Nucleic Acids Res. 2007;35(19):6571–6587.
  • Hamimes S, Arakawa H, Stasiak AZ, et al. RDM1, a novel RNA recognition motif (RRM)-containing protein involved in the cell response to cisplatin in vertebrates. J Biol Chem. 2005;280(10):9225–9235.
  • He J, Cui L, Zeng Y, et al. REGγ is associated with multiple oncogenic pathways in human cancers. BMC Cancer. 2012;12:75.
  • Li L, Dang Y, Zhang J, et al. REGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway. Nat Commun. 2015;6:6875.
  • Li W, Huang Q, Sun D, et al. RDM1 gene overexpression represents a therapeutic target in papillary thyroid carcinoma. Endocr Connect. 2017;6(8):700–707.
  • Tong L, Liu J, Yan W, et al. RDM1 plays an oncogenic role in human lung adenocarcinoma cells. Sci Rep. 2018;8(1):11525.
  • Chen Y, Sun Z, Zhong T. RDM1 promotes critical processes in breast cancer tumorigenesis. J Cell Mol Med. 2019;23(8):5432–5439.
  • Krejci L, Song B, Bussen W, et al. Interaction with Rad51 is indispensable for recombination mediator function of Rad52. J Biol Chem. 2002;277(42):40132–40141.
  • Lazaro-Trueba I, Arias C, Silva A. Double bolt regulation of Rad51 by p53: a role for transcriptional repression. Cell Cycle. 2006;5(10):1062–1065.
  • Meek DW. The p53 response to DNA damage. DNA Repair (Amst.). 2004;3(8–9):1049–1056.
  • Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40(2):179–204.
  • Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol. Cell. 2007;28(5):739–745.